Hospitals start pilot testing RFID to curb drug diversion

Article

M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).

Related Videos
© 2024 MJH Life Sciences

All rights reserved.